rxstat › Classes › Other Antihypertensives

Other Antihypertensives: shortage status in Canada

2 of the 3 other antihypertensives rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageAmbrisentan2 of 8 reported products affected · est. return Jun 30, 2026Partial shortageBosentan2 of 12 reported products affected · est. return Jun 30, 2027No current shortageSildenafil

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.